Trade CRVS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Corvus Pharmaceuticals, Inc. (CRVS) is trading at US$12.64, up 0.60% today as of Sep 21, 10:26 EDT. The company has a market capitalisation of US$1.22B. Over the past 52 weeks, CRVS has traded between US$5.74 and US$26.95. On Syfe you can trade CRVS with $0 commission and add it to your watchlist.
| Previous close | US$12.56 |
|---|---|
| Market cap | US$1.22B |
| 52-week range | US$5.74 – US$26.95 |
| Volume | 4.46M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.
Year: 2016
Goldman Sachs Initiates Corvus Pharmaceuticals at Buy With $40 Price Target
Apr 17, 11:27 AM · MT Newswires
Corvus Pharmaceuticals, Inc. (CRVS) stock is trading at US$12.64, +0.60% from the previous close of US$12.56.
The market cap for Corvus Pharmaceuticals, Inc. (CRVS) stock is approximately US$1.22B.
The 52-week high for Corvus Pharmaceuticals, Inc. (CRVS) stock is US$26.95.
The 52-week low for Corvus Pharmaceuticals, Inc. (CRVS) stock is US$5.74.
Corvus Pharmaceuticals, Inc. (CRVS) does not currently pay a dividend.
Stay on top of CRVS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
